43602-419-90 |
43602-419 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.075 mg/1 |
90 TABLET in 1 BOTTLE (43602-419-90) |
43602-420-10 |
43602-420 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.088 mg/1 |
1000 TABLET in 1 BOTTLE (43602-420-10) |
43602-420-30 |
43602-420 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.088 mg/1 |
30 TABLET in 1 BOTTLE (43602-420-30) |
43602-420-90 |
43602-420 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.088 mg/1 |
90 TABLET in 1 BOTTLE (43602-420-90) |
43602-421-10 |
43602-421 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.1 mg/1 |
1000 TABLET in 1 BOTTLE (43602-421-10) |
43602-421-30 |
43602-421 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.1 mg/1 |
30 TABLET in 1 BOTTLE (43602-421-30) |
43602-421-90 |
43602-421 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.1 mg/1 |
90 TABLET in 1 BOTTLE (43602-421-90) |
43602-422-10 |
43602-422 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.112 mg/1 |
1000 TABLET in 1 BOTTLE (43602-422-10) |
43602-422-30 |
43602-422 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.112 mg/1 |
30 TABLET in 1 BOTTLE (43602-422-30) |
43602-422-90 |
43602-422 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.112 mg/1 |
90 TABLET in 1 BOTTLE (43602-422-90) |
43602-423-10 |
43602-423 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.125 mg/1 |
1000 TABLET in 1 BOTTLE (43602-423-10) |
43602-423-30 |
43602-423 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.125 mg/1 |
30 TABLET in 1 BOTTLE (43602-423-30) |
43602-423-90 |
43602-423 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.125 mg/1 |
90 TABLET in 1 BOTTLE (43602-423-90) |
43602-424-10 |
43602-424 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.137 mg/1 |
1000 TABLET in 1 BOTTLE (43602-424-10) |
43602-424-30 |
43602-424 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.137 mg/1 |
30 TABLET in 1 BOTTLE (43602-424-30) |
43602-424-90 |
43602-424 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.137 mg/1 |
90 TABLET in 1 BOTTLE (43602-424-90) |
43602-425-10 |
43602-425 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.15 mg/1 |
1000 TABLET in 1 BOTTLE (43602-425-10) |
43602-425-30 |
43602-425 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.15 mg/1 |
30 TABLET in 1 BOTTLE (43602-425-30) |
43602-425-90 |
43602-425 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.15 mg/1 |
90 TABLET in 1 BOTTLE (43602-425-90) |
43602-426-10 |
43602-426 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.175 mg/1 |
1000 TABLET in 1 BOTTLE (43602-426-10) |